Dose Escalation Study of Liposomal Paclitaxel With/Without Capecitabine in Patients With Advanced Gastric Carcinoma

NCT00639522 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

18

Enrollment

INDUSTRY

Sponsor class

Conditions

Gastric Carcinoma

Interventions

DRUG: Liposomal paclitaxel and capecitabine

Sponsor

Nanjing Sike Pharmaceutical Co., Ltd.